Senvest Management’s Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share CTV.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-223,425
Closed -$203K 90
2022
Q1
$203K Hold
223,425
0.01% 69
2021
Q4
$228K Buy
+223,425
New +$278K 0.01% 70

Other funds holding CTV.WS

Senvest Management's CTV.WS Position: Q2 2022 in Review

Senvest Management sold out of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) in Q2 2022, closing a stake of 223,425 shares — an estimated $203K sold.

Senvest Management first reported a position in CTV.WS in Q4 2021 and held it in 2 quarters. The position peaked at $228K in Q4 2021. 23 funds tracked by Wall St. Rank hold CTV.WS as of Q2 2022.

  • Senvest Management reported no remaining Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q2 2022 after selling out during the quarter.
  • Senvest Management sold 223,425 Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q2 2022, an estimated $203K.
  • Senvest Management first reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 2 quarters.
  • Senvest Management's Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $228K in Q4 2021.
  • 23 funds tracked by Wall St. Rank held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q2 2022.

Based on Senvest Management's 13F filing for Q2 2022, filed 12 Aug 2022.